相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer
Karen A. Cadoo et al.
GYNECOLOGIC ONCOLOGY (2020)
Oncologic outcomes and morbidity following heated intraperitoneal chemotherapy at cytoreductive surgery for primary epithelial ovarian cancer: A systematic review and meta-analysis
Genevieve Bouchard-Fortier et al.
GYNECOLOGIC ONCOLOGY (2020)
A randomized phase II trial of secondary cytoreductive surgery (SCS) +/- carboplatin hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with recurrent platinum-sensitive ovarian cancer (EOC).
Oliver Zivanovic et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Epithelial ovarian cancer
Stephanie Lheureux et al.
LANCET (2019)
Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study
Joan L. Walker et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
HIPEC: HOPE or HYPE in the fight against advanced ovarian cancer?
C. Fotopoulou et al.
ANNALS OF ONCOLOGY (2018)
The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the German Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR), the Swiss and Austrian AGO, and the North-Eastern German Society of Gynaecologic Oncology
A. M. Dueckelmann et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2018)
Ovarian Cancer Treatment - Are We Getting Warmer?
David R. Spriggs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
W. J. van Driel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer
Alison E. Freimund et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2018)
OV21/PETROC: a randomized Gynecologic Cancer Intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer
D. M. Provencher et al.
ANNALS OF ONCOLOGY (2018)
The effect of thermal dose on hyperthermia-mediated inhibition of DNA repair through homologous recombination
Nathalie van den Tempel et al.
ONCOTARGET (2017)
Upregulated Heat Shock Proteins After Hyperthermic Chemotherapy Point to Induced Cell Survival Mechanisms in Affected Tumor Cells From Peritoneal Carcinomatosis
Tanja Grimmig et al.
CANCER GROWTH AND METASTASIS (2017)
Randomized trial of hyperthermic intraperitoneal chemotherapy (HIPEC) in women with primary advanced peritoneal, ovarian, and tubal cancer
Myong Cheol Lim et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Hyperthermic intra-peritoneal chemotherapy and anticancer immune response
Barbara Zunino et al.
ONCOIMMUNOLOGY (2016)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study
J. L. Lesnock et al.
BRITISH JOURNAL OF CANCER (2013)
How do cells respond to their thermal environment?
JR Lepock
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2005)
分享论文
